Performance of FDMT 4D Molecular | -5.2% in 12m
Compare FDMT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare 4D Molecular with its related Sector/Index XBI
Performance Duell FDMT vs XBI
| TimeFrame | FDMT | XBI |
|---|---|---|
| 1 Week | 0.40% | -4.68% |
| 1 Month | -2.77% | 2.20% |
| 3 Months | -33.2% | 4.12% |
| 6 Months | -46.7% | -3.48% |
| 12 Months | -5.16% | 22.61% |
| YTD | -29.1% | 7.10% |
| Rel. Perf. 1m | -0.39 | |
| Rel. Perf. 3m | -6.37 | |
| Rel. Perf. 6m | -6.54 | |
| Rel. Perf. 12m | -6.54 | |
| Spearman 1m | 0.57 | 0.47 |
| Spearman 3m | -0.80 | 0.70 |
Is 4D Molecular a good stock to buy?
No, based on ValueRay Fundamental Analyses, 4D Molecular (NASDAQ:FDMT) is currently (September 2024)
a stock to sell. It has a ValueRay Fundamental Rating of -72.21 and therefor a negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FDMT as of September 2024 is 12.54. This means that FDMT is currently overvalued and has a potential downside of -16.79% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FDMT as of September 2024 is 12.54. This means that FDMT is currently overvalued and has a potential downside of -16.79% (Sold with Premium).
Is FDMT a buy, sell or hold?
- Strong Buy: 6
- Buy: 5
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: FDMT is performing better - Values below 0%: FDMT is underperforming
Compare FDMT with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 4.54% | -6.26% | -53.35% | -27.34% |
| US NASDAQ 100 | QQQ | 6.19% | -4.85% | -49.22% | -25.01% |
| US Dow Jones Industrial 30 | DIA | 3.22% | -6.57% | -51.97% | -23.66% |
| German DAX 40 | DBXD | 3.64% | -8.17% | -49.50% | -19.76% |
| UK FTSE 100 | ISFU | 2.65% | -9.04% | -58.99% | -23.32% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 3.08% | -0.46% | -40.40% | 5.75% |
| Hongkong Hang Seng | HSI | 2.62% | -7.54% | -47.18% | 0.68% |
| Japan Nikkei 225 | EXX7 | 7.52% | -8.45% | -36.54% | -11.02% |
| India NIFTY 50 | INDA | 2.50% | -5.38% | -55.11% | -29.47% |
| Brasil Bovespa | EWZ | 2.11% | -9.65% | -38.16% | -5.40% |
FDMT 4D Molecular vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.47% | -3.36% | -54.04% | -29.68% |
| Consumer Discretionary | XLY | 2.92% | -8.16% | -48.66% | -11.25% |
| Consumer Staples | XLP | -0.18% | -8.84% | -58.49% | -23.31% |
| Energy | XLE | 6.17% | -1.65% | -46.99% | -3.02% |
| Financial | XLF | 3.57% | -9.49% | -56.57% | -35.90% |
| Health Care | XLV | 2.47% | -7.14% | -52.90% | -22.81% |
| Industrial | XLI | 4.64% | -5.92% | -50.88% | -26.23% |
| Materials | XLB | 5.06% | -4.36% | -48.77% | -16.81% |
| Real Estate | XLRE | 0.22% | -7.78% | -58.44% | -28.53% |
| Technology | XLK | 7.85% | -4.43% | -45.42% | -23.48% |
| Utilities | XLU | 0.90% | -6.94% | -68.79% | -28.92% |
| Aerospace & Defense | XAR | 5.61% | -6.77% | -51.14% | -31.50% |
| Biotech | XBI | 5.08% | -4.97% | -43.19% | -27.77% |
| Homebuilder | XHB | 4.80% | -6.19% | -54.51% | -42.76% |
| Retail | XRT | 5.38% | -2.26% | -43.42% | -23.81% |
Does 4D Molecular outperform its market, is FDMT a Sector Leader?
No, over the last 12 months 4D Molecular (FDMT) made -5.16%, while its related Sector, the SPDR S&P Biotech (XBI) made 22.61%.
Over the last 3 months FDMT made -33.23%, while XBI made 4.12%.
No, over the last 12 months 4D Molecular (FDMT) made -5.16%, while its related Sector, the SPDR S&P Biotech (XBI) made 22.61%.
Over the last 3 months FDMT made -33.23%, while XBI made 4.12%.
| Period | FDMT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -2.77% | 2.20% | 3.49% |
| 3 Months | -33.23% | 4.12% | 1.39% |
| 12 Months | -5.16% | 22.61% | 22.18% |